CFO
NGVT icon

CVA Family Office’s Ingevity NGVT Stock Holding History

CVA Family Office’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29K Buy
44
+21
+91% +$1.51K ﹤0.01% 1405
2026
Q1 		$1.64K Buy
+23
New +$1.57K ﹤0.01% 1573
2025
Q2 		– Sell
-11
Closed -$435 – 1394
2025
Q1 		$435 Buy
+11
New +$487 ﹤0.01% 1347

Other funds holding NGVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

CVA Family Office's NGVT Position: Q2 2026 in Review

CVA Family Office increased its Ingevity (NGVT) stake by 91% in Q2 2026, buying an estimated $1.51K and bringing the position to 44 shares worth $3.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1405.

CVA Family Office first reported a position in NGVT in Q1 2025 and has held it in 3 quarters since. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • CVA Family Office held 44 shares of Ingevity worth $3.29K as of Q2 2026.
  • CVA Family Office bought 21 Ingevity shares in Q2 2026, an estimated $1.51K.
  • Ingevity made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1405 holding.
  • CVA Family Office first reported a position in Ingevity in Q1 2025 and has held it in 3 quarters since.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.